Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas

被引:210
作者
Balch, CM
Soong, S
Smith, T
Ross, MI
Urist, MM
Karakousis, CP
Temple, WJ
Mihm, MC
Barnhill, RL
Jewell, WR
Wanebo, HJ
Desmond, R
机构
[1] Johns Hopkins Med Ctr, Baltimore, MD USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Morristown Mem Hosp, Morristown, NJ USA
[4] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Univ Calgary, Calgary, AB, Canada
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Univ Kansas, Kansas City, KS USA
[9] Roger Williams Hosp, Providence, RI USA
关键词
melanoma; surgical excision margins; neoplasm staging; Cox regression; risk factors;
D O I
10.1007/s10434-001-0101-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Intergroup Melanoma Surgical Trial began in 1983 to examine the optimal surgical margins of excision for primary melanomas of intermediate thickness (i.e., 1-4 mm). There is now a median 10-year follow-up. Methods: There were two cohorts entered into a prospective multi-institutional trial: (1) 468 patients with melanomas on the trunk or proximal extremity who randomly received a 2 cm or 4 cm radial excision margin and (2) 272 patients with melanomas on the head, neck, or distal extremities who received a 2 cm radial excision margin. Results: A local recurrence (LR) was associated with a high mortality rate, with a 5-year survival rate of only 9% (as a first relapse) or 11% (anytime) compared with an 86% survival for those patients who did trot have a LR (P < .0001). The 10-year survival for all patients with a LR was 5%. The 10-year survival rates were not significantly different when comparing 2 cm vs. 4 cm margins of excision (70% vs. 77%) or comparing the management of the regional lymph nodes (observation vs, elective node dissection). The incidences of LR were the same for patients having a 2 cm vs. 4 cm excision margin regardless of whether the comparisons were made as first relapse (0.4% vs. 0.9%) or at anytime (2.1% vs. 2.6%). When analyzed by anatomic site, the LR rates were 1.1% for melanomas arising on the proximal extremity, 3.1% for the trunk, 5.3% fur the distal extremities, and 9.4%, for the head and neck. The most profound influence on LR rates was the presence or absence of ulceration; it was 6.6% vs. 1.1% in the randomized group involving the trunk and proximal extremity and was 16.2% vs. 2.1% in the nun-randomized group involving the distal extremity and head and neck (P < .001). A multivariate (Cox) regression analysis showed that ulceration was an adverse and independent factor (P = .0001) as was head and neck melanoma site (P = .01), while the remaining factors were not significant (all with P > .12). Conclusion: For this group of melanoma patients, a local recurrence is associated with a high mortality rate, a 2-cm margin of excision is safe and ulceration of the primary melanoma is the most significant prognostic factor heralding an increased risk for a local recurrence.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 34 条
[11]   A COMPARISON OF PROGNOSTIC FACTORS AND SURGICAL RESULTS IN 1,786 PATIENTS WITH LOCALIZED (STAGE-1) MELANOMA TREATED IN ALABAMA, USA, AND NEW-SOUTH-WALES, AUSTRALIA [J].
BALCH, CM ;
SOONG, SJ ;
MILTON, GW ;
SHAW, HM ;
MCGOVERN, VJ ;
MURAD, TM ;
MCCARTHY, WH ;
MADDOX, WA .
ANNALS OF SURGERY, 1982, 196 (06) :677-684
[12]   CUTANEOUS MELANOMA - PROGNOSIS AND TREATMENT RESULTS WORLDWIDE [J].
BALCH, CM .
SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (06) :400-414
[13]  
BRESLOW A, 1977, SURG GYNECOL OBSTET, V145, P691
[14]  
CASCINELLI N, 1980, EUR J CANCER, V16, P1079
[15]   PROGNOSTIC FACTORS FOR STAGE-I MELANOMA OF THE SKIN - A REVIEW [J].
CASCINELLI, N ;
MARUBINI, E ;
MORABITO, A ;
BUFALINO, R .
STATISTICS IN MEDICINE, 1985, 4 (03) :265-278
[16]   ETIOLOGY AND PROGNOSIS OF LOCAL RECURRENCE IN MALIGNANT-MELANOMA OF THE SKIN [J].
CRUSE, CW ;
WELLS, KE ;
SCHROER, KR ;
REINTGEN, DS .
ANNALS OF PLASTIC SURGERY, 1992, 28 (01) :26-28
[17]  
Dong XD, 2000, CANCER-AM CANCER SOC, V88, P1063, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1063::AID-CNCR17>3.0.CO
[18]  
2-E
[19]   THE INFLUENCE OF RESECTION MARGIN ON PROGNOSIS IN CLINICAL STAGE 1 MALIGNANT-MELANOMA OF THE LOWER LEG [J].
ELBERG, JJ ;
POULSEN, H ;
LADEFOGED, C .
SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 1989, 23 (01) :59-63
[20]   OPTIMAL RESECTION MARGIN FOR CUTANEOUS MALIGNANT-MELANOMA [J].
ELDER, DE ;
GUERRY, D ;
HEIBERGER, RM ;
LAROSSA, D ;
GOLDMAN, LI ;
CLARK, WH ;
THOMPSON, CJ ;
MATOZZO, I ;
VANHORN, M .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1983, 71 (01) :66-72